# Blood Markers of Early Pancreas Cancer

> **NCT03568630** · — · RECRUITING · sponsor: **University of Nebraska** · enrollment: 1250 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2
- PreDiabetes
- Pancreas Cyst
- Chronic Pancreatitis
- Genetic Predisposition to Disease
- Inherited Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03568630
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2018-07-26
- **Primary completion:** 2028-07
- **Final completion:** 2028-07
- **Target enrollment:** 1250 (ESTIMATED)
- **Last updated:** 2026-02-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03568630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03568630, "Blood Markers of Early Pancreas Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03568630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*